Upstream / Downstream
Explore pathways related to this product.
Our U.S. Offices Are Closed
Our U.S. offices are closed in observance of Thanksgiving. We will reopen on Monday, December 1st.
Thank you for your patience.
To Purchase # 8921SC
|8921SC||10 µg (With Carrier)||$199.00|
|8921SF||10 µg (Carrier Free)||$199.00|
|8921LC||50 µg (With Carrier)||$599.00|
|8921LF||50 µg (Carrier Free)||$599.00|
|$ 0. 00|
Find answers on our FAQs page.
PTM information and tools available.
Human Interleukin-8 (hIL-8) #8921
The purity of recombinant hIL-8 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hIL-8 and staining overnight with Coomassie Blue.Learn more about how we get our images
Gallery: Human Interleukin-8 (hIL-8) #8921
- The purity of recombinant hIL-8 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hIL-8 and staining overnight with Coomassie Blue.
- The upregulation of CD11b expression on primary human neutrophils with increasing concentrations of hIL-8 was assessed. After 20 minute treatment with hIL-8, cells were stained with an anti-CD11b antibody and analyzed by flow cytometry.
Recombinant human IL-8 (hIL-8) Ser28-Ser99 (Accession #NM_000584) was produced in E.coli at Cell Signaling Technology.
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hIL-8. All lots are greater than 98% pure.Molecular Formula:
Recombinant hIL-8 does not have a Met on the amino terminus and has a calculated MW of 8,386. DTT-reduced and non-reduced protein migrate as 8 kDa polypeptides. The expected amino-terminal SAKEL of recombinant hIL-8 was verified by amino acid sequencing.Bioactivity:
The bioactivity of recombinant hIL-8 was determined by upregulation of CD11b expression on primary human neutrophils. The ED50 of each lot is between 1-5 ng/ml.Endotoxin:
Less than 0.01 ng endotoxin/1 μg hIL-8.
SC: A 0.22 μm filtered solution of 0.25 mg/ml hIL-8 in PBS, pH 7.2 containing 20 μg BSA per 1 μg hIL-8.
LC: A 0.22 μm filtered solution of 0.33 mg/ml hIL-8 in PBS, pH 7.2 containing 20 μg BSA per 1 μg hIL-8.
SF: A 0.22 μm filtered solution of 0.25 mg/ml hIL-8 in PBS, pH 7.2.
LF: A 0.22 μm filtered solution of 0.33 mg/ml hIL-8 in PBS, pH 7.2.Storage: Stable at 4°C for 1 year after receipt. Maintain sterility. Do not store frozen.
The prototypical CXC chemokine, IL-8, is best known for effects on neutrophils, specifically its ability to act as a chemoattractant and activate degranulation and respiratory burst (1,2,3).
IL-8 is produced by a number of cell types including monocytes, T cells, neutrophils, fibroblasts, endothelial cells, and others (1). In addition to its effects on neutrophils, IL-8 promotes angiogenesis, inhibits endothelial cell apoptosis, and promotes the proliferation of melanoma cells in an autocrine fashion (1). As a result, IL-8 may be a contributing factor to the development of certain cancers (1,2). There are two distinct receptors for IL-8, CXCR1 and CXCR2; both are G protein-coupled receptors (1). Ligand binding induces Ca2+ mobilization and activates the PI3K, PKC, Rho, and Rac pathways (1,3).
For Research Use Only. Not For Use In Diagnostic Procedures. Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.